Vyne Therapeutics
Price & Volume
Stats
See more52W Range | $0.28-$1.59 |
Market Cap | $21.2M |
Shares Short | 104,336 |
Financials
See moreRevenue (12 Mos) | $454,000 |
Revenue Growth (YoY) | -57.4% |
Gross Profit (12 Mos) | $454,000 |
Diluted EPS | -$0.51 |
News
See moreYahoo Finance • 2 days ago
VYNE Therapeutics declares $0.38/share merger-contingent special dividend
Yahoo Finance • 7 months ago
BC-Most Active Stocks
Yahoo Finance • 8 months ago
VYNE Therapeutics GAAP EPS of -$0.17 misses by $0.04, revenue of $0.2M beats by $0.1M
About
CEO | Mr. David T. Domzalski |
CFO | Mr. Tyler Zeronda CPA |
Address | P.O. BOX 125, Stewartsville, NJ, United States, 08886 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |